These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2085437)

  • 1. Alterations of band 3 transport protein by cellular aging and disease: erythrocyte band 3 and glucose transporter share a functional relationship.
    Bosman GJ; Kay MM
    Biochem Cell Biol; 1990 Dec; 68(12):1419-27. PubMed ID: 2085437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modifications of brain and erythrocyte band 3 during aging and disease.
    Kay MM; Rapcsak SZ; Bosman GJ; Goodman JR
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):919-44. PubMed ID: 8960771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Band 3 and its peptides during aging, radiation exposure, and Alzheimer's disease: alterations and self-recognition.
    Kay MM; Lake D; Cover C
    Adv Exp Med Biol; 1995; 383():167-93. PubMed ID: 8644501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional topography of band 3: specific structural alteration linked to functional aberrations in human erythrocytes.
    Kay MM; Bosman GJ; Lawrence C
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):492-6. PubMed ID: 2829189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of human band-3 mutation associated with increased anion transport.
    Kay MM; Bosman G; Johnson RC; Poulin J; Lawrence C; Goodman J
    Exp Clin Immunogenet; 1994; 11(4):209-21. PubMed ID: 7857667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane protein band 3 alteration associated with neurologic disease and tissue-reactive antibodies.
    Kay MM; Goodman J; Goodman S; Lawrence C
    Exp Clin Immunogenet; 1990; 7(3):181-99. PubMed ID: 2383405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological evidence that band 3 is the major glucose transporter of the human erythrocyte membrane.
    Langdon RG; Holman VP
    Biochim Biophys Acta; 1988 Nov; 945(1):23-32. PubMed ID: 3179308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mapping of the active site of an aging antigen: senescent cell antigen requires lysine(s) for antigenicity and is located on an anion-binding segment of band 3 membrane transport protein.
    Kay MM; Lin FB
    Gerontology; 1990; 36(5-6):293-305. PubMed ID: 1706294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte anion transporter and antibrain immunoreactivity in chorea-acanthocytosis. A contribution to etiology, genetics, and diagnosis.
    Bosman GJ; Bartholomeus IG; De Grip WJ; Horstink MW
    Brain Res Bull; 1994; 33(5):523-8. PubMed ID: 8186997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transport protein is structurally and immunologically related to band 3 and senescent cell antigen.
    Kay MM
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1731-5. PubMed ID: 3856855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigen.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):131-53. PubMed ID: 8513271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in membrane protein band 3 associated with accelerated erythrocyte aging.
    Kay MM; Flowers N; Goodman J; Bosman G
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5834-8. PubMed ID: 2527366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and erythrocyte anion transporter protein, band 3, as a marker for Alzheimer's disease: structural changes detected by electron microscopy, phosphorylation, and antibodies.
    Kay MM; Goodman J
    Gerontology; 1997; 43(1-2):44-66. PubMed ID: 8996829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Band 3 in aging and neurological disease.
    Kay MM
    Ann N Y Acad Sci; 1991; 621():179-204. PubMed ID: 1859086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to band 3 during aging and disease and aging interventions.
    Kay MM; Wyant T; Goodman J
    Ann N Y Acad Sci; 1994 May; 719():419-47. PubMed ID: 7516632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and function of multiple anion transporter proteins in brain tumor cell lines in relation to glucose transport.
    Goodman JR; Gamble D; Kay MM
    Brain Res Bull; 1994; 33(4):411-7. PubMed ID: 8124579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glucose and nucleoside transport proteins in neonatal pig erythrocytes using monoclonal antibodies against band 4.5 polypeptides of adult human and pig erythrocytes.
    Craik JD; Good AH; Gottschalk R; Jarvis SM; Paterson AR; Cass CE
    Biochem Cell Biol; 1988 Aug; 66(8):839-52. PubMed ID: 3143374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory autoantibody and cellular aging and removal.
    Kay MM
    Adv Exp Med Biol; 1994; 347():161-92. PubMed ID: 7976729
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttranslational changes in band 3 in aging and Alzheimer's disease: do anion and glucose transport changes reflect or foreshadow the eventual metabolic abnormalities?
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):271-2. PubMed ID: 9551658
    [No Abstract]   [Full Text] [Related]  

  • 20. Human erythrocyte sugar transport is incompatible with available carrier models.
    Cloherty EK; Heard KS; Carruthers A
    Biochemistry; 1996 Aug; 35(32):10411-21. PubMed ID: 8756697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.